Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025
Talphera (NASDAQ: TLPH), a specialty pharmaceutical company specializing in innovative therapies for medically supervised settings, has scheduled its first quarter 2025 financial results announcement and corporate update for Wednesday, May 14, 2025. The company will release its financial results after market close, followed by a live webcast and conference call at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time.
Investors can access the webcast through Talphera's website or join the conference call by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (international) using conference ID 58894. A replay of the webcast will be available on the company's website for 90 days following the event.
Talphera (NASDAQ: TLPH), un'azienda farmaceutica specializzata in terapie innovative per ambienti medici supervisionati, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 e un aggiornamento aziendale per mercoledì 14 maggio 2025. La società pubblicherà i risultati finanziari dopo la chiusura del mercato, seguiti da una webcast dal vivo e una conference call alle 16:30 ora della costa est/13:30 ora della costa pacifica.
Gli investitori potranno accedere alla webcast tramite il sito web di Talphera o partecipare alla conference call chiamando il numero 1-800-836-8184 (Nord America) o 1-646-357-8785 (internazionale) utilizzando il codice conferenza 58894. Una registrazione della webcast sarà disponibile sul sito dell'azienda per 90 giorni dopo l'evento.
Talphera (NASDAQ: TLPH), una compañía farmacéutica especializada en terapias innovadoras para entornos médicos supervisados, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 y una actualización corporativa para el miércoles 14 de mayo de 2025. La empresa publicará sus resultados financieros tras el cierre del mercado, seguido de una transmisión en vivo y una llamada en conferencia a las 4:30 p.m. hora del Este / 1:30 p.m. hora del Pacífico.
Los inversores pueden acceder a la transmisión en vivo a través del sitio web de Talphera o unirse a la llamada en conferencia marcando 1-800-836-8184 (Norteamérica) o 1-646-357-8785 (internacional) usando el ID de conferencia 58894. La repetición de la transmisión estará disponible en el sitio web de la compañía durante 90 días después del evento.
Talphera (NASDAQ: TLPH)는 의료 감독 환경을 위한 혁신적인 치료법을 전문으로 하는 전문 제약 회사로서, 2025년 5월 14일 수요일에 2025년 1분기 재무 실적 발표 및 기업 업데이트를 예정하고 있습니다. 회사는 시장 마감 후 재무 실적을 발표하며, 이어서 동부 표준시 오후 4시 30분 / 태평양 표준시 오후 1시 30분에 라이브 웹캐스트와 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 Talphera 웹사이트를 통해 웹캐스트에 접속하거나, 컨퍼런스 ID 58894를 사용하여 북미 지역은 1-800-836-8184, 국제 전화는 1-646-357-8785로 전화하여 컨퍼런스 콜에 참여할 수 있습니다. 웹캐스트 재방송은 행사 종료 후 90일 동안 회사 웹사이트에서 이용 가능합니다.
Talphera (NASDAQ : TLPH), une société pharmaceutique spécialisée dans les thérapies innovantes pour les environnements médicaux supervisés, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 ainsi qu'une mise à jour d'entreprise pour le mercredi 14 mai 2025. La société publiera ses résultats financiers après la clôture du marché, suivis d'une webdiffusion en direct et d'une conférence téléphonique à 16h30 heure de l'Est / 13h30 heure du Pacifique.
Les investisseurs peuvent accéder à la webdiffusion via le site web de Talphera ou rejoindre la conférence téléphonique en composant le 1-800-836-8184 (Amérique du Nord) ou le 1-646-357-8785 (international) en utilisant l'ID de conférence 58894. La rediffusion de la webdiffusion sera disponible sur le site de la société pendant 90 jours après l'événement.
Talphera (NASDAQ: TLPH), ein spezialisiertes Pharmaunternehmen, das innovative Therapien für medizinisch überwachte Umgebungen anbietet, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 sowie ein Unternehmensupdate für Mittwoch, den 14. Mai 2025 terminiert. Das Unternehmen wird die Finanzergebnisse nach Börsenschluss veröffentlichen, gefolgt von einer Live-Webcast und Telefonkonferenz um 16:30 Uhr Eastern Time / 13:30 Uhr Pacific Time.
Investoren können über die Webseite von Talphera auf den Webcast zugreifen oder sich über die Telefonnummer 1-800-836-8184 (Nordamerika) bzw. 1-646-357-8785 (international) mit der Konferenz-ID 58894 in die Telefonkonferenz einwählen. Eine Aufzeichnung des Webcasts wird für 90 Tage nach der Veranstaltung auf der Unternehmenswebseite verfügbar sein.
- None.
- None.
Webcast Information
The webcast can be accessed here or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.
Conference Call Information
Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA).
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-first-quarter-financial-results-and-corporate-update-call-and-webcast-on-wednesday-may-14-2025-302448966.html
SOURCE Talphera, Inc.